Suppr超能文献

可重新定位的Lotus™经导管主动脉瓣治疗后永久起搏器植入的发生率及预测因素

Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve.

作者信息

Zaman Sarah, McCormick Liam, Gooley Robert, Rashid Hashrul, Ramkumar Satish, Jackson Damon, Hui Samuel, Meredith Ian T

机构信息

Monash Cardiovascular Research Centre, Department of Medicine (Monash Medical Centre), School of Clinical Sciences, Monash University.

Cardiovascular Division, Monash Heart, Monash Medical Centre, Melbourne, Victoria, Australia.

出版信息

Catheter Cardiovasc Interv. 2017 Jul;90(1):147-154. doi: 10.1002/ccd.26857. Epub 2016 Nov 12.

Abstract

OBJECTIVES

To determine the incidence and predictors of permanent pacemaker (PPM) requirement following transcatheter aortic valve replacement (TAVR) with the mechanically expanded Lotus Valve System (Boston Scientific).

BACKGROUND

Pacemaker implantation is the most common complication following TAVR. Predictors of pacing following TAVR with the Lotus valve have not been systematically assessed.

METHODS

Consecutive patients with severe aortic stenosis who underwent Lotus valve implantation were prospectively recruited at a single-centre. Patients with a pre-existing PPM were excluded. Baseline ECG, echocardiographic and multiple detector computed tomography as well as procedural telemetry and depth of implantation were independently analyzed in a blinded manner. The primary endpoint was 30-day incidence of pacemaker requirement (PPM implantation or death while pacing-dependent). Multivariate analysis was performed to identify independent predictors of the primary endpoint.

RESULTS

A total of 104 consecutive patients underwent TAVR with the Lotus valve with 9/104 (9%) with a pre-existing PPM excluded. New or worsened procedural LBBB occurred in 78%. Thirty-day incidence of the primary pacing endpoint was 28%. The most common indication for PPM implantation was complete heart block (CHB) (69%). Independent predictors of the primary endpoint included pre-existing RBBB (hazard ratio [HR] 2.8, 95% CI 1.1-7.0; P = 0.032) and depth of implantation below the noncoronary cusp (NCC) (HR 2.4, 95% CI 1.0-5.7; P = 0.045).

CONCLUSIONS

Almost a third of Lotus valve recipients require pacemaker implantation within 30 days. The presence of pre-existing RBBB and the depth of prosthesis implantation below the NCC were significant pacing predictors. © 2016 Wiley Periodicals, Inc.

摘要

目的

确定使用机械扩张式Lotus瓣膜系统(波士顿科学公司)进行经导管主动脉瓣置换术(TAVR)后永久性起搏器(PPM)植入的发生率及预测因素。

背景

起搏器植入是TAVR后最常见的并发症。使用Lotus瓣膜进行TAVR后起搏的预测因素尚未得到系统评估。

方法

在单中心前瞻性招募连续接受Lotus瓣膜植入的重度主动脉瓣狭窄患者。排除既往有PPM的患者。对基线心电图、超声心动图、多层螺旋计算机断层扫描以及手术遥测和植入深度进行独立的盲法分析。主要终点是起搏器植入需求的30天发生率(PPM植入或因依赖起搏而死亡)。进行多变量分析以确定主要终点的独立预测因素。

结果

共有104例连续患者接受了Lotus瓣膜TAVR,其中9/104例(9%)因既往有PPM被排除。78%的患者出现新的或加重的手术相关左束支传导阻滞(LBBB)。主要起搏终点的30天发生率为28%。PPM植入最常见的指征是完全性心脏传导阻滞(CHB)(69%)。主要终点的独立预测因素包括既往存在右束支传导阻滞(RBBB)(风险比[HR]2.8,95%置信区间1.1 - 7.0;P = 0.032)以及植入深度低于无冠瓣叶(NCC)(HR 2.4,95%置信区间1.0 - 5.7;P = 0.045)。

结论

近三分之一接受Lotus瓣膜植入的患者在30天内需要植入起搏器。既往存在RBBB以及假体植入深度低于NCC是显著的起搏预测因素。© 2016威利期刊公司。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验